Arkolith/Insider Trading/RARE/Form 4

Crombez Eric

EVP and Chief Medical OfficerUltragenyx Pharmaceutical Inc. (RARE) · full profile →Form 4 · filed May 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$29K
Net Open-Market Flow
-$29K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 5, 2025Sell(S)520$39.24$20K72K
Apr 21, 2025Sell(S)242$35.11$8K72K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-063792) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML